Published by Josh White on 1st July 2020
(Sharecast News) - Life sciences company OptiBiotix Health announced on Wednesday that its wholly-owned subsidiary, ProBiotix Health, has entered into a non-exclusive distribution agreement with Actial Farmaceutica for the distribution of its 'CholBiome' and 'CholBiome X3' products, in four new territories in the Asia-Pacific region.